BROGI, SIMONE Statistiche



Mostra records
Risultati 1 - 20 di 138 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
Characterization of stenocephol from Seriphidium stenocephalum as potent HepG2 cell growth and glycogen phosphorylase inhibitor 1-gen-2023 Shafiq, N.; Arshad, U.; Brogi, S.; Rashid, M.; Rafiq, N.; Parveen, S.
Computation to Fight SARS-CoV-2 (COVID-19) 1-gen-2023 Brogi, S.; Calderone, V.
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents 1-gen-2023 Al-Sanea, M. M.; Hamdi, A.; Brogi, S.; S Tawfik, S.; Othman, D. I. A.; Elshal, M.; Ur Rahman, H.; Parambi, D. G. T.; M Elbargisy, R.; Selim, S.; Mostafa, E. M.; Mohamed, A. A. B.
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains 1-gen-2023 Carullo, G.; Di Bonaventura, G.; Rossi, S.; Lupetti, V.; Tudino, V.; Brogi, S.; Butini, S.; Campiani, G.; Gemma, S.; Pompilio, A.
Developmental landscape of computational techniques to explore the potential phytochemicals from Punica granatum peels for their antioxidant activity in Alzheimer’s disease 1-gen-2023 Parveen, S.; Batool, A.; Shafiq, N.; Rashid, M.; Sultan, A.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M.
Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations 1-gen-2023 Yazdani, B.; Sirous, H.; Enguita, F. J.; Brogi, S.; Wing, P. A. C.; Fassihi, A.
Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes 1-gen-2023 Flori, L.; Brogi, S.; Sirous, H.; Calderone, V.
Editorial: Advances in green synthesis for drug discovery 1-gen-2023 Allais, F.; Brogi, S.; Castro, G. R.; Vidali, V. P.
Exploration of phenolic acid derivatives as inhibitors of SARS-CoV-2 main protease and receptor binding domain: potential candidates for anti-SARS-CoV-2 therapy 1-gen-2023 Shafiq, N.; Mehroze, A.; Sarwar, W.; Arshad, U.; Parveen, S.; Rashid, M.; Farooq, A.; Rafiq, N.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M.
Identification of Sesamin from Sesamum indicum as a Potent Antifungal Agent Using an Integrated in Silico and Biological Screening Platform 1-gen-2023 Wadhwa, K.; Kaur, H.; Kapoor, N.; Brogi, S.
Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation 1-gen-2023 Brogi, S.
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going? 1-gen-2023 Tabanelli, R.; Brogi, S.; Calderone, V.
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 1-gen-2022 Federico, S.; Khan, T.; Fontana, A.; Brogi, S.; Benedetti, R.; Sarno, F.; Carullo, G.; Pezzotta, A.; Saraswati, A. P.; Passaro, E.; Pozzetti, L.; Papa, A.; Relitti, N.; Gemma, S.; Butini, S.; Pistocchi, A.; Ramunno, A.; Vincenzi, F.; Varani, K.; Tatangelo, V.; Patrussi, L.; Baldari, C. T.; Saponara, S.; Gorelli, B.; Lamponi, S.; Valoti, M.; Saccoccia, F.; Giannaccari, M.; Ruberti, G.; Herp, D.; Jung, M.; Altucci, L.; Campiani, G.
Butein as a potential binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: a computer-aided analysis 1-gen-2022 Kapoor, N.; Ghorai, S. M.; Khuswaha, P. K.; Bandichhor, R.; Brogi, S.
Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature 1-gen-2022 Brogi, S.; Tabanelli, R.; Calderone, V.
Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases 1-gen-2022 Brogi, S.; Ibba, R.; Rossi, S.; Butini, S.; Calderone, V.; Gemma, S.; Campiani, G.
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors 1-gen-2022 Saccoccia, F.; Pozzetti, L.; Gimmelli, R.; Butini, S.; Guidi, A.; Papoff, G.; Giannaccari, M.; Brogi, S.; Scognamiglio, V.; Gemma, S.; Ruberti, G.; Campiani, G.
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 1-gen-2022 Campiani, G.; Khan, T.; Ulivieri, C.; Staiano, L.; Papulino, C.; Magnano, S.; Nathwani, S.; Ramunno, A.; Lucena-Agell, D.; Relitti, N.; Federico, S.; Pozzetti, L.; Carullo, G.; Casagni, A.; Brogi, S.; Vanni, F.; Galatello, P.; Ghanim, M.; Mccabe, N.; Lamponi, S.; Valoti, M.; Ibrahim, O.; O'Sullivan, J.; Turkington, R.; Kelly, V. P.; Vanwemmel, R.; Diaz, J. F.; Gemma, S.; Zisterer, D.; Altucci, L.; De Matteis, A.; Butini, S.; Benedetti, R.
Design and Synthesis of Oligopeptidic Parvulin Inhibitors 1-gen-2022 Relitti, N.; Prasanth Saraswati, A.; Carullo, G.; Papa, A.; Monti, A.; Benedetti, R.; Passaro, E.; Brogi, S.; Calderone, V.; Butini, S.; Gemma, S.; Altucci, L.; Campiani, G.; Doti, N.
Exploring the anti-SARS-CoV-2 main protease potential of FDA approved marine drugs using integrated machine learning templates as predictive tools 1-gen-2022 Attiq, N.; Arshad, U.; Brogi, S.; Shafiq, N.; Imtiaz, F.; Parveen, S.; Rashid, M.; Noor, N.